NYSE$NHC

National HealthCare Corporation · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

NHC's financial performance for Q3 2020 reflected a slight revenue increase and solid earnings per share.

National HealthCare Corporation (NHC) reported a 1.4% increase in net operating revenues and CARES Act funding for Q3 2020, totaling $250,626,000. GAAP net income attributable to NHC was $12,849,000, with a reported GAAP diluted earnings per share of $0.84.

  • Net operating revenues and CARES Act funding increased by 1.4% compared to Q3 2019, reaching $250,626,000.
  • Excluding CARES Act funding, net operating revenues would have decreased by 3.5% compared to Q3 2019.
  • GAAP net income attributable to NHC was $12,849,000, compared to $19,461,000 for the third quarter of 2019.
  • Reported GAAP diluted earnings per share was $0.84, while the adjusted diluted earnings per share was $0.88.

Headline financials

Total Revenue

$251M

Previous: $247M+1.4%
EPS (adj)

$0.88

Previous: $0.84+4.8%
Capital Expenditures

-$17.7M

Previous: -$19.7M+9.9%
Free Cash Flow

-$4.87M

Previous: -$209K-2229.2%
Net Income

$12.8M

Previous: $19.5M-34.0%
Operating Income

$7.02M

Previous: $6.57M+6.9%
Gross Profit

$251M

Previous: $247M+1.4%
Cash & Equivalents

$184M

Previous: $59.3M+210.1%
Total Assets

$1.34B

Previous: $1.31B+2.4%
Stock-Based Comp

$518K

Previous: $340K+52.4%

Revenue & EPS history

NHC · Revenue · Quarterly

$251M

Q3 2020+1.4%vs Q3 2019

Revenue by segment

NHC · $260M total across 2 segments · Q1 2023

  • Net patient revenues
    $258M+2.8%
  • Other revenues
    $2.06M-87.5%

Forward guidance

Forward-looking statements involve risks and uncertainties detailed in NHC's filings with the SEC. These include potential liabilities, economic conditions, healthcare regulations, and changes in Medicare and Medicaid payment levels.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

+0.1%

Avg return

Earnings day

+1.7%

Avg return

5 days after

+1.8%

Avg return

30 days after

60%

39 / 65 earnings

Positive

+12.2%

Q2 2023

Best reaction

-14.0%

Q4 2009

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.8%+11.8%+12.9%
Q4 2025+2.0%-4.7%-3.7%
Q3 2025+1.1%+3.4%+7.8%
Q1 2025+1.6%-3.1%-3.3%
Q4 2024+0.8%+0.1%-0.2%
Q3 2024+4.5%-0.1%-4.8%
Q2 2024+3.2%+3.7%+6.4%
Q1 2024+0.9%+4.4%+7.4%
Q4 2023+5.8%+7.1%-0.1%
Q3 2023+1.8%+3.9%+14.2%
Q2 2023+12.2%+12.6%+12.5%
Q1 2023+1.9%+5.4%+11.5%
Q4 2022-2.4%-3.9%-8.2%
Q3 2022-3.2%-1.0%-1.3%
Q2 2022+1.1%+1.9%+0.8%
Q1 2022+2.8%+0.8%+1.9%
Q4 2021+0.5%+0.4%+9.6%
Q3 2021+5.9%+1.3%-10.0%
Q2 2021-0.8%-2.4%-5.9%
Q1 2021-1.5%-1.6%+2.4%
Q4 2020+3.7%+10.3%+20.5%
Q3 2020-1.8%+13.0%+2.3%
Q2 2020+5.8%+5.0%-1.2%
Q1 2020-0.0%-5.0%+5.4%
Q4 2019-0.2%-8.4%-16.6%
Q3 2019-0.4%+0.1%+1.1%
Q2 2019-0.6%+0.4%-5.3%
Q1 2019+0.1%+1.4%+2.3%
Q4 2018+1.8%-0.2%-4.2%
Q3 2018-2.3%-3.5%-2.1%
Q2 2018+1.7%+4.4%+5.3%
Q1 2018+3.0%+3.8%+8.3%
Q4 2017-7.1%-2.5%-3.3%
Q3 2017-1.0%+2.9%+0.4%
Q2 2017+0.0%+2.3%-3.8%
Q1 2017-1.1%-1.2%-2.2%
Q4 2016+1.0%+0.8%+0.3%
Q3 2016-2.1%+1.0%+7.6%
Q2 2016+1.9%+2.6%+4.7%
Q1 2016-0.6%
Q4 2015-1.6%
Q3 2015+0.5%
Q2 2015-3.4%
Q1 2015+0.1%
Q4 2014+1.0%
Q3 2014+1.9%
Q2 2014+0.4%
Q1 2014+2.3%
Q4 2013-0.4%
Q3 2013+0.7%
Q2 2013+1.5%
Q1 2013-0.3%
Q4 2012+1.2%
Q3 2012+1.8%
Q2 2012-1.0%
Q1 2011-4.9%
Q1 2012+3.2%
Q4 2011-0.9%
Q3 2010+7.9%
Q3 2011+7.9%
Q4 2009-14.0%
Q4 2010-14.0%
Q2 2010-14.0%
Q2 2011-14.0%
Q1 2010+3.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro